Evozyne combines evolution and deep learning technology to create highly functional novel proteins — Natural Machines™ — to solve longstanding challenges in therapeutics and sustainability. By amplifying a protein’s function based on the rules of nature, we address complex, high-impact problems.  From developing life-changing patient treatments to making carbon capture a reality, Evozyne is committed to making a healthier, more sustainable world. 

Fidelity Management and Research Company

Valor Equity Partners

NVentures

OrbiMed

Paragon Biosciences

Evozyne

Today, we honor the life and legacy of Dr. Martin Luther King, Jr. His dream of a united, compassionate world where kindness prevails, and equality thrives continues to live on. #martinlutherkingjr 

Great news to start 2024! Biotech veteran Marc Yoskowitz joins Evozyne as our new CEO. He will be leading Evozyne as we focus on drug discovery through our generative AI platform.

Read more: https://lnkd.in/g2_bnHCF

#ceo 

Evozyne was recently featured in Chicago NBC 5 news story on AI drug development. The segment, featuring CEO Mike Gamson, highlighted the potential of AI to expedite new therapies and cures for those who need it the most, saving time, money and potentially lives. 

Check it out: https://lnkd.in/gJcJHnEg
 
#ai #drugdevelopment  

A-Alpha Bio is a company focused on protein engineering and drug discovery.

A-Alpha Bio

XtalPi is a company specializing in AI-driven drug discovery and development.

XtalPi

Owkin is a company leveraging technology for drug discovery and development.

Owkin

Eikon Therapeutics is a startup focused on protein engineering and drug discovery.

Eikon Therapeutics

Ventus Therapeutics is a startup specializing in protein engineering and drug discovery.

Ventus Therapeutics

BigHat Biosciences, Inc. is a startup focused on protein engineering and drug discovery.

BigHat Biosciences, Inc.

Evozyne is a biotechnology company that harnesses the power of evolution to create novel proteins aimed at addressing challenges in therapeutic development. The company focuses on enhancing protein performance to enable commercial-scale solutions for new products and contribute to a healthier world.

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general	Jul 1, 2024 11:59 AM	fb49c244
public peers	general	Jun 30, 2024 2:22 PM	88232e74
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Jun 30, 2024 3:09 PM	a47aa343
company summary	general
signals	general
crunchbase trigger	general
crunchbase profile	general
li profile	general	Jun 30, 2024 2:22 PM	82883979
translate crunchbase fundingrounds	general
peers	general
news basic	general	Jun 30, 2024 2:22 PM	086f4ca0
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:EVOZYNE

Evozyne